Zytiga 500 mg (Abiraterone Acetate TABLET) 500 MG

ZYTIGA 500 MG tablets contain abiraterone acetate, a medication used in cancer treatment. This oral tablet is manufactured by Janssen Inc. in Canada and is available in a 60-tablet pack.

Strength

500 MG

Pack Size

Manufacturer / TM Owner

JANSSEN INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ZYTIGA 500 MG tablets are commonly used in the management of certain types of cancer. Abiraterone acetate, the active ingredient, is often prescribed as part of a treatment regimen for advanced prostate cancer. Patients may wonder, 'What is ZYTIGA used for?' and the primary use is to help control the progression of cancer in specific cases.

Side Effects

When taking ZYTIGA 500 MG tablets, patients may experience various effects. Commonly reported effects include fatigue, joint pain, and swelling in the legs or feet. Some individuals may also notice changes in blood pressure or blood sugar levels. It's important to discuss any persistent or severe effects with a healthcare provider.

Precautions & Warnings

Handling ZYTIGA 500 MG tablets requires careful consideration. Patients should follow the prescribed dosage and administration instructions provided by their healthcare provider. It's crucial to avoid crushing or breaking the tablets, as this can alter the intended release of the medication. Additionally, regular monitoring of blood pressure and blood sugar levels may be necessary.

Avoid Interactions

ZYTIGA 500 MG tablets can interact with other medications, including those metabolized by the liver's cytochrome P450 system. Patients should inform their healthcare provider about all medications they are taking, including over-the-counter drugs and supplements. Alcohol consumption should be discussed with a healthcare provider, as it may affect the efficacy or safety of the medication.

Frequently Asked Questions

ZYTIGA 500 MG tablets are primarily used in the treatment of certain types of cancer, particularly advanced prostate cancer.

ZYTIGA 500 MG tablets should be taken orally, exactly as prescribed by your healthcare provider. Do not crush or break the tablets.

Common effects may include fatigue, joint pain, and swelling in the legs or feet. Always consult your healthcare provider for personalized advice.

It's important to discuss alcohol consumption with your healthcare provider, as it may interact with ZYTIGA 500 MG.

If you miss a dose, contact your healthcare provider for guidance. Do not double the dose to make up for a missed one.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.